EQIX vs IMCR · P/E 79, rev $5.07B vs rev $222.6M
Equinix Inc (EQIX) versus Immunocore Holdings Ltd (IMCR) — a side-by-side from cached financials, not a winner call.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
EQIX currently screens at market cap $74.23B and trailing P/E 79.4. IMCR currently screens at market cap $1.45B.
Not investment advice. Open the EQIX and IMCR stock pages for the full models.
Not investment advice.